Sign in
4

Changes in Ownership

Immix Biopharma, Inc. Filed Acc 0001493152-26-026425

Options or other derivatives

  • CEO and Chairman acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rachman Ilya M · CEO and Chairman

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-22 Grant or award : show line 1 in the form Stock Option (Right to Buy) +500,000 500,000 D
Loading xslF345X06/ownership.xml…